Exploring the effects of BCI-FES hand therapy on swallowing and speech in stroke patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This exploratory study investigates the impact of a closed-loop Brain-Computer Interface Functional Electrical Stimulation (BCI-FES) therapy on dysphagia and aphasia in chronic stroke patients. The therapy aims to enhance neurorehabilitation by utilizing EEG signals to provide feedback during motor imagery tasks, which may improve both hand function and communication abilities. Participants will engage in high-intensity training with the BCI-FES device, designed to stimulate movement and provide sensory feedback. The study is open-label and conducted at a single center, focusing on the potential cross-system effects of this innovative approach.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age: Participants must be aged 18 years or older.
* Post-Stroke Phase: Participants must be within the chronic post-stroke phase (time since ischemic or haemorrhagic stroke greater than 3 months).
* Motor Impairment: Participants must exhibit disabling left or right residual arm paresis ("left/right arm motor drift" part of the NIHSS score ≥1).
* Speech/Swallowing Impairment: Participants must have:

  * Aphasia (AAT-Skala zum Kommunikationsverhalten score ≤3), and/or
  * Dysphagia (MUCCS-N score ≥2).
* Stable Neurological Status: No relevant changes in neurological status in the past 4 weeks (self-reported).
* Motor Function: Participants must be able to raise at least 1 block similar to the ones in Box-and-Block-Test.
* Cognitive Understanding: Participants must be able to understand basic spoken instructions.
* Sitting Tolerance: Participants must be able to maintain a sitting position for at least 60 minutes.
* Willingness to Participate: Participants must be willing to participate in the study and able to understand and sign the informed consent.

Exclusion Criteria:

* Cognitive Impairments: Cognitive impairments that, in the investigator's judgment, could limit understanding of task instructions.
* Stroke Location: Participants with a brainstem and/or cerebellar stroke.
* Previous Stroke: Participants with a previous disabling stroke.
* Hemi-Neglect: Pronounced hemi-neglect at the last documented therapy visit that limits compliance with treatment intervention (investigator's judgment).
* Anosognosia: Pronounced anosognosia at the last documented therapy visit that limits compliance with treatment intervention (investigator's judgment).
* Spasticity: Severe spasticity in the affected limb, resulting in complete rigidity in flexion or extension.
* Seizure Disorders: Participants with uncontrolled epilepsy (investigator's judgement) or epileptic seizure within the last month.
* Intracranial Pressure: Known ongoing elevated intracranial pressure.
* Implanted Medical Devices: Participants with implanted medical devices with contraindication for FES such as pacemakers.
* Metallic Fragments: Participants with implanted metallic fragments in the extremity planned for FES that would limit the use of functional electrical stimulation (FES).
* Unhealed Injuries: Unrecovered fractures or skin/tissue lesions in the FES stimulated extremity.
* Joint Issues: Ossification, contraction, or stiffness of the wrist joint in the FES stimulated extremity that would limit treatment.
* Botulinum Toxin: Participants who received botulinum-toxin treatment within 6 weeks prior to study inclusion and/or for whom botulinum-toxin treatment is planned during the study duration.
* Co-morbidities: The following conditions will exclude participation:

  * Chronic Obstructive Pulmonary Disease (Stage IV).
  * Cardiac insufficiency (NYHA Stage IV).
  * Severe acute infections.
  * Significant circulatory disturbances in the stimulated extremity.
  * Sensory disorders that significantly impair the patient's ability to feel pain or react to unsuitable proprioceptive stimuli.
  * Any other general medical conditions that, in the investigator's judgment, limit the safety or performance of study procedures (investigator's judgement).
* Electrical Stimulation Intolerance: Known inability to tolerate cutaneous electrical stimulation.

Where it's running

• Department for Neurology, Medical University of Innsbruck
  Innsbruck, Tyrol, Austria Recruiting

Study contacts

• Principal investigator: Michael Knoflach, Assoc.-Prof. — Medical University Innsbruck
• Study coordinator: Simon Sollereder, MSc
• Email: simon.sollereder@vascage.at
• Phone: +43 664 1004838

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Remotely Delivered Step Count Rehab After Stroke

  This study tests a remotely guided program that uses step counting and six clinician sessions to see if people who had a stroke can feasibly use it at home.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07649135

• Best Care for Acute Stroke in General Wards

  A nurse-led program called BEST CARE ICTUS_HC is tested in hospitals without Stroke Units to see if it reduces stroke complications and helps recovery after an acute ischemic or hemorrhagic stroke.

  Recruiting University of Malaga · Antequera, Málaga and 3 other locations · NCT07627399

• Minocycline added to standard IV thrombolysis in acute ischemic stroke

  This trial tests whether giving minocycline around the time of IV thrombolysis improves functional recovery after an acute ischemic stroke.

  Recruiting at 2 sites Phase 3 Beijing Tiantan Hospital · Liaocheng, Shandong and 2 other locations · NCT07526987

• Changes in brain response after transcranial electrical stimulation in stroke patients

  This study tests whether transcranial electrical stimulation added to rehabilitation can alter brain blood flow and oxygen use in adults who have had a stroke, from subacute to several years post-stroke.

  Recruiting Mahidol University · Salaya, Changwat Nakhon Pathom · NCT07433972

• Noninvasive brain stimulation plus cognitive-motor dual-task gait training to improve thinking and walking after stroke

  This trial will test whether adding high-definition noninvasive brain stimulation (tDCS or tACS) to cognitive-motor dual-task gait training and standard physical therapy helps thinking, brain activity, spinal reflexes, and walking in adults 2 weeks to 5 years after a stroke.

  Recruiting Mahidol University · Nakhon Pathom · NCT07236216

• Left atrial function in people with unexplained (cryptogenic) stroke.

  This will see if lower left atrial strain on a heart ultrasound is linked to unexplained (cryptogenic) stroke and to higher risk of another stroke in adults who had a stroke without a known cause.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07224178

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.